ADIAL PHARMACEUTICALS
Adial Pharmaceuticals, LLC engages in the development of prescription medications for addiction and related disorders in the United States. The company's research pipeline includes AD04, a compound that completed Phase IIb study for the treatment of alcohol use disorders; and AD01, which completed Phase I clinical-stage for treating addictive behaviors.
ADIAL PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2010-01-01
Address:
Charlottesville, Virginia, United States
Country:
United States
Website Url:
http://www.adialpharma.com
Total Employee:
1+
Status:
Active
Contact:
434-422-9800
Email Addresses:
[email protected]
Total Funding:
26.04 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail ReCAPTCHA Microsoft Azure DNS US Privacy User Signal Mechanism Google Google Cloud Facebook Sharer
Similar Organizations
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Keystone Capital Partners
Keystone Capital Partners investment in Post-IPO Equity - Adial Pharmaceuticals
Richard Gilliam
Richard Gilliam investment in Post-IPO Equity - Adial Pharmaceuticals
Bespoke Growth Partners
Bespoke Growth Partners investment in Post-IPO Equity - Adial Pharmaceuticals
Keystone Capital Partners
Keystone Capital Partners investment in Post-IPO Equity - Adial Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2022-08-22 | Adial Pharmaceuticals Names Cary Claiborne as Chief Executive Officer |
Official Site Inspections
http://www.adialpharma.com Semrush global rank: 7.12 M Semrush visits lastest month: 585
- Host name: 172.67.178.165
- IP address: 172.67.178.165
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
